LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company pioneering vaccine development technologies to build a pipeline of vaccine programs to protect against and prevent severe infections caused by pathogens that have become resistant to antimicrobial treatments.

LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases.In addition to our proprietary research, we also develop vaccines together with GSK.

COM:LMTBIO

LimmaTech Biologics AG

Analysis Not Available